MX2008002779A - Granulado triturado deshidratado y metodos. - Google Patents
Granulado triturado deshidratado y metodos.Info
- Publication number
- MX2008002779A MX2008002779A MX2008002779A MX2008002779A MX2008002779A MX 2008002779 A MX2008002779 A MX 2008002779A MX 2008002779 A MX2008002779 A MX 2008002779A MX 2008002779 A MX2008002779 A MX 2008002779A MX 2008002779 A MX2008002779 A MX 2008002779A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- granulate
- dried milled
- milled granulate
- particle size
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Medicinal Preparation (AREA)
- Processing Of Solid Wastes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Glanulating (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invencion, se relaciona con un metodo para producir un granulado humedo deshidratado que tiene un tamano de particula promedio conveniente y una distribucion de tamano de particula y las formas de dosificacion producidas de ese granulado.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71258005P | 2005-08-30 | 2005-08-30 | |
US11/507,240 US20070048373A1 (en) | 2005-08-30 | 2006-08-21 | Dried milled granulate and methods |
PCT/US2006/033779 WO2007027720A2 (en) | 2005-08-30 | 2006-08-29 | Dried milled granulate and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2008002779A true MX2008002779A (es) | 2008-04-07 |
Family
ID=37804492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2008002779A MX2008002779A (es) | 2005-08-30 | 2006-08-29 | Granulado triturado deshidratado y metodos. |
Country Status (12)
Country | Link |
---|---|
US (1) | US20070048373A1 (es) |
EP (3) | EP2359811B1 (es) |
JP (1) | JP5144519B2 (es) |
AT (2) | ATE458475T1 (es) |
CA (1) | CA2621079C (es) |
DE (1) | DE602006012503D1 (es) |
DK (1) | DK2198855T3 (es) |
ES (3) | ES2398637T3 (es) |
HK (3) | HK1111622A1 (es) |
MX (1) | MX2008002779A (es) |
PT (1) | PT2198855E (es) |
WO (1) | WO2007027720A2 (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
NZ544826A (en) * | 2003-07-25 | 2008-07-31 | Warner Chilcott Co Inc | A doxycycline metal complex in a solid dosage form |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US7883039B2 (en) * | 2007-02-27 | 2011-02-08 | Collette Nv | Continuous granulating and drying apparatus including measurement units |
US8173169B2 (en) * | 2007-07-11 | 2012-05-08 | Hikma Pharmaceuticals | Formulation and process for the preparation of modafinil |
RU2567723C2 (ru) | 2009-07-22 | 2015-11-10 | Грюненталь Гмбх | Стабильная при окислении, прочная на излом лекарственная форма |
MX2012006240A (es) * | 2009-12-02 | 2012-10-03 | Aptalis Pharma Ltd | Microcapsulas de fexofenadina y composiciones que contienen las mismas. |
TR201000688A2 (tr) * | 2010-01-29 | 2011-08-22 | B�Lg�� Mahmut | Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar. |
FR2959130A1 (fr) * | 2010-04-21 | 2011-10-28 | Sanofi Aventis | Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant. |
JP6133009B2 (ja) * | 2010-08-11 | 2017-05-24 | 協和発酵キリン株式会社 | トピラマート顆粒 |
RU2604676C2 (ru) | 2010-09-02 | 2016-12-10 | Грюненталь Гмбх | Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль |
TR201009396A2 (tr) * | 2010-11-11 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Desloratadin granüller |
KR101380836B1 (ko) * | 2011-01-18 | 2014-04-09 | 한국기계연구원 | 상온진공과립분사 공정을 위한 취성재료 과립 및 이를 이용한 코팅층의 형성방법 |
JP5830412B2 (ja) * | 2011-03-02 | 2015-12-09 | ライオン株式会社 | 水難溶性薬物と賦形剤との粉砕物の製造方法、造粒粒子の製造方法、錠剤の製造方法 |
CA2839123A1 (en) | 2011-07-29 | 2013-02-07 | Grunenthal Gmbh | Tamper-resistant tablet providing immediate drug release |
DK2736497T3 (da) | 2011-07-29 | 2017-11-13 | Gruenenthal Gmbh | Stød-resistent tablet, der tilvejebringer en øjeblikkelig frigivelse af et lægemiddel. |
WO2013156453A1 (en) | 2012-04-18 | 2013-10-24 | Grünenthal GmbH | Tamper resistant and dose-dumping resistant pharmaceutical dosage form |
US9630909B2 (en) | 2013-06-27 | 2017-04-25 | Mylan Laboratories Ltd | Process for the preparation of nepafenac |
AU2014289187B2 (en) | 2013-07-12 | 2019-07-11 | Grunenthal Gmbh | Tamper-resistant dosage form containing ethylene-vinyl acetate polymer |
MX371372B (es) * | 2013-11-26 | 2020-01-28 | Gruenenthal Gmbh | Preparacion de una composicion farmaceutica en polvo por medio de criomolienda. |
CA2998259A1 (en) | 2015-09-10 | 2017-03-16 | Grunenthal Gmbh | Protecting oral overdose with abuse deterrent immediate release formulations |
MX2016013830A (es) * | 2015-10-27 | 2017-05-10 | Shinetsu Chemical Co | Eter de celulosa porosa no ionico soluble en agua que tiene excelente solubilidad y metodo para producir el mismo. |
WO2022241159A1 (en) * | 2021-05-12 | 2022-11-17 | Spectrix Therapeutics, LLC | Compositions and methods |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5234957A (en) * | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
IL92343A0 (en) * | 1988-12-20 | 1990-07-26 | Gist Brocades Nv | Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them |
US5178878A (en) * | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
ZA937277B (en) * | 1992-09-30 | 1994-05-19 | Ascent Pharma Inc | Calsium polycarbophil sprinkle |
US5503846A (en) * | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
US6077533A (en) * | 1994-05-25 | 2000-06-20 | Purdue Pharma L.P. | Powder-layered oral dosage forms |
US6039275A (en) * | 1996-07-04 | 2000-03-21 | Holland Sweetener Company V.O.F. | Aspartame powders for powder mixtures |
CA2284132C (en) * | 1997-04-01 | 2004-09-07 | Cima Labs Inc. | Blister package and packaged tablet |
US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
JPH1121236A (ja) * | 1997-07-01 | 1999-01-26 | Ohara Yakuhin Kogyo Kk | ロキソプロフェン・ナトリウム固形製剤 |
US6387410B1 (en) * | 1998-09-10 | 2002-05-14 | Norton Healthcare Ltd | Anti-inflammatory pharmaceutical formulations |
US6740341B1 (en) * | 1998-11-25 | 2004-05-25 | Cima Labs Inc. | Taste masking rapid release coating system |
DE19859636A1 (de) * | 1998-12-23 | 2000-06-29 | Hexal Ag | Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff |
JP2003508422A (ja) * | 1999-09-02 | 2003-03-04 | ノストラム・ファーマスーティカルズ・インコーポレイテッド | 放出制御ペレット製剤 |
KR100911779B1 (ko) * | 2001-05-25 | 2009-08-12 | 세파론, 인코포레이티드 | 모다피닐을 포함하는 고형 제약 제제 |
US7323192B2 (en) * | 2001-09-28 | 2008-01-29 | Mcneil-Ppc, Inc. | Immediate release tablet |
US6723348B2 (en) * | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
US6827946B2 (en) * | 2001-12-05 | 2004-12-07 | Collegium Pharmaceutical, Inc. | Compositions containing both sedative and non-sedative antihistamines |
US20050065183A1 (en) * | 2003-07-31 | 2005-03-24 | Indranil Nandi | Fexofenadine composition and process for preparing |
US7207505B2 (en) * | 2004-06-04 | 2007-04-24 | Bender Martin P | Method for producing small granules |
-
2006
- 2006-08-21 US US11/507,240 patent/US20070048373A1/en not_active Abandoned
- 2006-08-29 DK DK10001313.5T patent/DK2198855T3/da active
- 2006-08-29 MX MX2008002779A patent/MX2008002779A/es active IP Right Grant
- 2006-08-29 ES ES11157456T patent/ES2398637T3/es active Active
- 2006-08-29 EP EP11157456A patent/EP2359811B1/en active Active
- 2006-08-29 CA CA2621079A patent/CA2621079C/en active Active
- 2006-08-29 DE DE602006012503T patent/DE602006012503D1/de active Active
- 2006-08-29 AT AT06813925T patent/ATE458475T1/de not_active IP Right Cessation
- 2006-08-29 PT PT10001313T patent/PT2198855E/pt unknown
- 2006-08-29 ES ES06813925T patent/ES2339979T3/es active Active
- 2006-08-29 EP EP10001313A patent/EP2198855B1/en active Active
- 2006-08-29 EP EP06813925A patent/EP1919454B1/en active Active
- 2006-08-29 JP JP2008529209A patent/JP5144519B2/ja active Active
- 2006-08-29 AT AT10001313T patent/ATE539739T1/de active
- 2006-08-29 WO PCT/US2006/033779 patent/WO2007027720A2/en active Application Filing
- 2006-08-29 ES ES10001313T patent/ES2379333T3/es active Active
-
2008
- 2008-05-23 HK HK08105730.6A patent/HK1111622A1/xx unknown
-
2010
- 2010-12-15 HK HK10111702.4A patent/HK1145146A1/xx unknown
-
2012
- 2012-01-17 HK HK12100538.5A patent/HK1160010A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JP5144519B2 (ja) | 2013-02-13 |
DE602006012503D1 (de) | 2010-04-08 |
ATE458475T1 (de) | 2010-03-15 |
HK1111622A1 (en) | 2008-08-15 |
JP2009505798A (ja) | 2009-02-12 |
ES2379333T3 (es) | 2012-04-25 |
EP1919454B1 (en) | 2010-02-24 |
ATE539739T1 (de) | 2012-01-15 |
EP2359811A1 (en) | 2011-08-24 |
WO2007027720A3 (en) | 2007-08-02 |
CA2621079C (en) | 2014-02-18 |
EP2198855B1 (en) | 2012-01-04 |
EP1919454A2 (en) | 2008-05-14 |
HK1145146A1 (en) | 2011-04-08 |
ES2398637T3 (es) | 2013-03-20 |
US20070048373A1 (en) | 2007-03-01 |
ES2339979T3 (es) | 2010-05-27 |
EP2359811B1 (en) | 2012-11-14 |
DK2198855T3 (da) | 2012-04-02 |
HK1160010A1 (en) | 2012-08-10 |
CA2621079A1 (en) | 2007-03-08 |
EP2198855A1 (en) | 2010-06-23 |
WO2007027720A2 (en) | 2007-03-08 |
PT2198855E (pt) | 2012-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2008002779A (es) | Granulado triturado deshidratado y metodos. | |
MX2009005004A (es) | Microorganismos o fracciones de los mismos capaces de activar inmunidad celular contra carbohidratos. | |
TWI449540B (en) | Process for the production of an abuse-proofed dosage form | |
EP2241586A4 (en) | SILICULAR PARTICLES, METHOD FOR THE PRODUCTION THEREOF; ORGANIC POLYMERIC COMPOSITION, CERAMIC MATERIAL AND MANUFACTURING METHOD THEREFOR | |
EP1948852A4 (en) | REFERENCE ELECTRODE AND METHOD FOR PRODUCING THE REFERENCE ELECTRODE | |
EP1945159A4 (en) | MAGNETIC NANO-SCALE PARTICLE COMPOSITIONS AND ASSOCIATED THERAPEUTIC METHODS | |
MX2009003984A (es) | Particulas submicrobianas amorfas. | |
TW200722374A (en) | Precipitated silicas with a particular pore size distribution | |
EP1862431A4 (en) | METHOD OF MANUFACTURING INP MICROPARTICLES AND INP MICROTEXTILE DISPERSION SOLUTION PRODUCED BY THIS METHOD | |
WO2007133346A3 (en) | Imprint lithography method and system | |
EP2072462A4 (en) | METHOD FOR MANUFACTURING FINE PARTICLE DISPERSION OF METAL COMPOUND AND DISPERSION THEREOF | |
MX2010003013A (es) | Inhibicion de angiogenesis. | |
EP1880762A4 (en) | PROCESS FOR PREPARING MICROMETRIC AND NANOMETER PARTICLES WITH LABILE PRODUCTS | |
EP1885394A4 (en) | PRODUCTION OF MULTIVALENT PARTICLES LIKE VIRUSES | |
HK1169811A1 (en) | The orally rapidly disintegrating tablet that contains two or more types of particles | |
EP2191890A4 (en) | PROCESS FOR PRODUCING FINE PARTICLES AND FINE PARTICLES | |
EP1728823A4 (en) | FLAME RETARDANT, FLAME RETARDANT COMPOSITIONS AND METHOD FOR PRODUCING FLAME RETARDANT | |
SI1610878T1 (sl) | Postopek za proizvodnjo delcev | |
SG111177A1 (en) | Fine particle powder production | |
MX2009013170A (es) | Particulas de silice y metodos para prepararlas y utilizarlas. | |
EP1951197A4 (en) | METHOD OF CHECKING THE PARTICLE SIZE | |
EP1852178A4 (en) | PROCESS FOR PRODUCING COATED FINE PARTICLES | |
EP1848536A4 (en) | PROCESS FOR REDUCING THE PARTICLE SIZE OF GLASSIC POLYSACCHARIDES | |
AU305983S (en) | Distribution box | |
EP1918258A4 (en) | PROCESS FOR THE PRODUCTION OF SPHERICAL INORGANIC PARTICLES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |